| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.013 | 0.8 |